Annals of neurology

SARS-CoV-2 and Mitochondrial Proteins Found in Brain Cell Tiny Particles of COVID-19 Patients

Updated

Abstract

Mean levels of SARS-CoV-2 N protein were higher in post-acute sequelae of SARS-CoV-2 (PASC) patients with neuropsychiatric manifestations compared to those without.

  • SARS-CoV-2 S1 and nucleocapsid proteins were elevated in all PASC sub-groups compared to healthy controls.
  • Subunit 6 of mitochondrial respiratory chain complex I and subunit 10 of complex III levels were significantly lower in PASC with neuropsychiatric manifestations.
  • Neuroprotective mitochondrial proteins Humanin and MOTS-c showed decreased levels in PASC with neuropsychiatric manifestations compared to controls.
  • Levels of voltage-dependent anion-selective channel protein 1 and N-methyl-D-aspartate receptor 1 were reduced in both PASC groups.
  • Calcium channel proteins were decreased only in PASC patients with neuropsychiatric manifestations.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

No authors declare any conflict‐of‐interest except for Dr. Goetzl who has filed an application covering this lab methodology with the US Patent and Trademark Office.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free